PM

Paul J. Maddon

PP Progenics Pharmaceuticals: 33 patents #1 of 53Top 2%
CU Columbia University: 8 patents #146 of 2,492Top 6%
PC Psma Development Company: 4 patents #3 of 10Top 30%
FB Facet Biotech: 2 patents #11 of 31Top 40%
CY Cytodyn: 2 patents #1 of 14Top 8%
SB Smithkline Beckman: 2 patents #61 of 166Top 40%
AM Amgen: 2 patents #1,289 of 2,867Top 45%
PB Pdl Biopharma: 1 patents #15 of 40Top 40%
Overall (All Time): #58,742 of 4,157,543Top 2%
48
Patents All Time

Issued Patents All Time

Showing 25 most recent of 48 patents

Patent #TitleCo-InventorsDate
10500274 Methods for reducing viral load in HIV-1 infected patients William Olson, Daniel C. Pevear, Robert J. Israel, Jose D. Murga 2019-12-10
9695248 PSMA antibodies and uses thereof Gerald P. Donovan, William Olson, Norbert Schuelke, Jason Gardner, Dangshe Ma 2017-07-04
8821877 Methods for inhibiting HIV-1 replication involving the administration of an anti-CCR5 receptor monoclonal antibody and small molecule CCR5 receptor antagonist William Olson, Daniel C. Pevear, Robert J. Israel, Jose D. Murga 2014-09-02
8470330 PSMA antibodies and uses thereof Gerald P. Donovan, William Olson, Norbert Schuelke, Jason Gardner, Dangshe Ma +2 more 2013-06-25
8114965 Compositions of PSMA antibodies Gerald P. Donovan, William Olson, Norbert Schuelke, Jason Gardner, Dangshe Ma +2 more 2012-02-14
7935797 CCR5 chemokine receptor-specific monoclonal antibodies capable of inhibiting HIV-1 cell fusion Graham P. Allaway, Virginia M. Litwin, William Olson 2011-05-03
7901685 Methods for assaying inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion Graham P. Allaway, Virginia M. Litwin 2011-03-08
7862994 Methods for inhibiting HIV-1 envelope glycoprotein-medicated membrane fusion Graham P. Allaway, Virginia M. Litwin 2011-01-04
7858298 Methods of inhibiting human immunodeficiency virus type 1 (HIV-1) infection through the administration of CCR5 chemokine receptor antagonists Graham P. Allaway, Virginia M. Litwin, William Olson 2010-12-28
7850971 PSMA antibodies and protein multimers Gerald P. Donovan, William Olson, Norbert Schuelke, Jason Gardner, Dangshe Ma 2010-12-14
7851600 Anti-CCR5 antibody William Olson, Naoya Tsurushita, Paul R. Hinton, Maximiliano Vasquez 2010-12-14
7736649 Methods of inhibiting human immunodeficiency virus infection through the administration of synergistic combinations of anti-CCR5 monoclonal antibodies, fusion inhibitors, and CD4-GP120 binding inhibitors William Olson 2010-06-15
7666419 Anti-CCR5 antibody William Olson, Naoya Tsurushita, Paul R. Hinton, Maximillano Vasquez 2010-02-23
7592014 Stabilized viral envelope proteins and uses thereof James Binley, Norbert Schuelke, William Olson, John P. Moore 2009-09-22
7479553 Nucleic acids encoding mutant disulfide bond-stabilized human immunodeficiency virus type 1 (HIV-1) gp140 envelope glycoproteins James Binley, Norbert Schuelke, William Olson, John P. Moore 2009-01-20
7446177 Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection William Olson 2008-11-04
7345153 Compounds capable of inhibiting HIV-1 infection Virginia M. Litwin, Graham P. Allaway 2008-03-18
7138119 Compositions and methods for inhibition of HIV-1 infection William Olson 2006-11-21
7122185 Anti-CCR5 antibody William Olson, Naoya Tsurushita, Paul R. Hinton, Maximillano Vasquez 2006-10-17
7118859 Methods for inhibiting HIV-1 infection Virginia M. Litwin, Graham P. Allaway 2006-10-10
7070991 Cells expressing a CD4-IgG2 chimeric heterotetramer Gary A. Beaudry 2006-07-04
7060273 Methods for inhibiting HIV-1 infection William Olson 2006-06-13
7022324 Stabilized viral envelope proteins and uses thereof James Binley, Norbert Schuelke, William Olson, John P. Moore 2006-04-04
7022323 Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection William Olson 2006-04-04
6972126 Methods for using resonance energy transfer-based assay of HIV-1 envelope glycoprotein-mediated membrane fusion, and kits for practicing same Graham P. Allaway, Virginia M. Litwin 2005-12-06